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Abstract
The spectrum of human congenital malformations known as DiGeorge syndrome (DGS) is replicated in mice by mutation of
Tbx1. Vegfa has been proposed as a modifier of DGS, based in part on the occurrence of comparable phenotypes in Tbx1
and Vegfa mutant mice. Many additional genes have been shown to cause DGS-like phenotypes in mice when mutated;
these generally intersect in some manner with Tbx1, and therefore impact the same developmental processes in which Tbx1
itself is involved. In this study, using Tie2Cre, we show that endothelial-specific mutation of the gene encoding the VEGFA
coreceptor neuropilin-1 (Nrp1) also replicates the most prominent terminal phenotypes that typify DGS. However, the
developmental etiologies of these defects are fundamentally different from those caused by absence of TBX1. In Tie2Cre/
Nrp1 mutants, initial pharyngeal organization is normal but subsequent pharyngeal organ growth is impaired, second heart
field differentiation is normal but cardiac outflow tract cushion organization is distorted, neural crest cell migration is
normal, and palatal mesenchyme proliferation is impaired with no change in apoptosis. Our results demonstrate that
impairment of VEGF-dependent endothelial pathways leads to a spectrum of DiGeorge syndrome-type malformations,
through processes that are distinguishable from those controlled by Tbx1.
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Introduction
DiGeorge syndrome (DGS) is a human genetic disorder char-
acterized by a range of cardiac outflow tract (OFT) and great
vessel malformations, craniofacial malformations, hypoplasia of the
thymus and parathyroid pharyngeal organs, and cognitive impair-
ment [1]. Most cases of DGS are associated with hemizygous
microdeletions of chromosome22q11.2. The gene encoding TBX1,
a member of the T-box containing family of transcription factors, is
located within this region and haploinsufficiency of this gene
appears to be responsible for most of the manifestations of DGS in
humans. In mice, heterozygosity of Tbx1 can result in impaired 4
th
pharyngeal arch artery development and thereby in type B
interrupted aortic arch [2–4], one of the prominent cardiovascular
phenotypes in human DGS. Complete absence of TBX1 in mice
results in a high severity and penetrance of almost all of the
phenotypes seen in human DGS, including cardiac outflow and
arch artery defects, pharyngeal organ hypoplasia, and craniofacial
malformations [3,5].
A common theme in the development of the organs that are
impacted in DGS is their dependence on neural crest cells.
However, Tbx1 is not expressed in and does not function in neural
crest cells [6–7]. Rather, Tbx1 functions in pharyngeal ectoderm,
mesoderm, or endoderm (depending on the organ system
investigated), and acts through a variety of tissue interactions
and downstream effectors in different developmental processes.
Tbx1 is expressed in endothelial cells, although mutation of Tbx1 in
vascular endothelium had no consequence in cardiac, pharyngeal,
or craniofacial morphogenesis [8–9]. Tbx1 function in endotheli-
um is required for proper lymphatic vessel development [10],
although lymphatic defects are not generally thought to contribute
to or be part of the clinical spectrum associated with DiGeorge
syndrome.
A number of genes cooperate with Tbx1 and therefore result in
some or all DGS phenotypes when mutated in mice. One such
gene is Crkl [11–12], which is located near Tbx1 and is therefore
also deleted in most cases of DGS. Many other genes that are not
physically linked to Tbx1 have been shown to interact functionally
or genetically with Tbx1 in one or more of the developmental
processes in which Tbx1 participates [2,12–22]. Finally, other
genes are known to cause some DGS-like phenotypes when
mutated in mice, but have not been analyzed to determine if or
how they intersect with Tbx1.
Mouse embryos lacking VEGF164, the major isoform of the
Vegfa gene (which is not chromosomally linked to Tbx1), exhibit
craniofacial, pharyngeal organ, pharyngeal arch artery, and
cardiac outflow tract defects and therefore resemble DGS [23].
Among other sites, Vegfa is expressed in the myocardium of the
heart outflow tract, in pharyngeal endoderm adjacent to the
pharyngeal arch arteries, and in the developing thymus and palate
[23–25], which is consistent with these phenotypes. Based on a
number of arguments (see Discussion), Vegfa has been proposed to
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of the DiGeorge syndrome [23]. Vegfa deficiency is also associated
with generally impaired vascular development, specifically in the
formation of small and medium caliber vessels [23,26–27],
representing a known function of VEGF in promoting angiogenic
vessel branching [27–28].
Neuropilin-1 (NRP1) is a dual ligand coreceptor, mediating the
effects of VEGF164 when coupled to the VEGF receptor FLK1
(VEGFR2), and the effects of members of the Sema3 family when
coupled to several plexins [29]. NRP1 can also mediate VEGF
signaling in the absence of VEGFR2 in some contexts [30]. Global
knockout of Nrp1 in mice is embryonic lethal around E12.5;
cardiovascular defects in these embryos included a general
deficiency in small and medium caliber blood vessel formation,
altered pharyngeal arch artery formation, and a failure to septate
the outflow tract into the ascending aorta and pulmonary trunk
[31], all similar to phenotypes seen in Vegfa mutants [23].
Conditional Nrp1 disruption in endothelial cells using Tie2Cre
[32] allowed survival to full term, and replicated several of the
cardiovascular defects seen in the global Nrp1 knockout, including
general peripheral vascular branching deficiency and failure to
septate the outflow tract [33].
In this study, we have investigated the developmental role of
Nrp1 function, specifically in endothelial cell lineages, with
particular attention to the developmental processes that are
impacted in DGS. In addition to the cardiac outflow tract defect
(lack of outflow tract septation) that has already been reported
[33], we find that Tie2Cre/Nrp1 mutants have pharyngeal arch
artery, pharyngeal organ, and craniofacial defects that collectively
resemble those seen in Vegfa mutants and in human DGS.
However, we find that the developmental basis of each defect in
Tie2Cre/Nrp1 mutants is dissimilar to what occurs in Tbx1 null
embryos. We suggest that defective vascular organization and
endothelial cell dysfunction underlie the phenotypes of Vegfa and
Nrp1 mutants. More importantly, our results demonstrate a
requirement for Nrp1 function in endothelium that when
compromised leads to DiGeorge syndrome-like defects through
mechanisms distinct to those associated with Tbx1 deficiency.
Results
Endothelial-specific deletion of Nrp1 causes DiGeorge
syndrome-like defects in mice
Embryos with conditional knockout of Nrp1 driven by Tie2Cre
survived to full term in normal numbers, but died in the
immediate postnatal period. The overall size of E18.5 Tie2Cre/
Nrp1 mutants was not obviously different, and limb development
was normal at all stages (Fig. S1A), implying no general embryo-
wide growth deficiency or developmental delay. In more than 20
E18.5 mutant embryos, we confirmed that all Tie2Cre/Nrp1
mutants had a single cardiac outflow vessel (a phenotype called
persistent truncus arteriosus or common arterial trunk; Fig. 1A–B),
as previously reported [33]. All Tie2Cre/Nrp1 mutants also had a
ventricular septal defect, which is a hemodynamic necessity of a
common arterial trunk. In addition, all Tie2Cre/Nrp1 mutant
embryos examined at late stages had some malformation of the
great vessels (Fig. 1A–B): a type B interrupted aortic arch was most
common, additional great vessel malformations included retro-
esophageal right subclavian artery and a right sided dorsal aorta.
In 10 out of 10 Tie2Cre/Nrp1 mutants examined at E18.5, the
thymus was hypoplastic (Fig. 1C); morphometric quantitation
(Fig. 1D) indicated an average 50% decrease in thymic size in
mutants relative to littermate controls. Although not quantitated,
the thyroid was also hypoplastic in all Tie2Cre/Nrp1 mutants
(Fig. 1E–F), whereas the parathyroids were present and seemingly
of proper size (Fig. 1E–F and Fig. S1B–C). Cleft palate occurred in
approximately half (9/17) of Tie2Cre/Nrp1 mutants (Fig. 1G–H);
we also observed occasional examples of mandibular hypoplasia
(Fig. S1D–E), although in most Tie2Cre/Nrp1 mutants, the
mandible was not obviously dysmorphic. In summation,
Tie2Cre/Nrp1 mutants have a high or complete penetrance of
cardiac outflow tract, great vessel, pharyngeal organ, and
craniofacial defects that collectively typify DiGeorge syndrome
in humans and that are also seen with high or complete
penetrance in Tbx1 and Vegfa mutant mice.
Figure 1. Endothelial-specific deletion of Nrp1 causes DiGeorge
syndrome defects in E18 mice. A,B, Whole mount views of the
outflow region of the heart. The Tie2Cre/Nrp1 mutant (B) has a common
arterial trunk (CAT) and lacks the arch of the aorta (aAo). Other
abbreviations: Ao, ascending aorta; lca, left carotid artery; PT,
pulmonary trunk; rca, right carotid artery. C, Thymuses from two
control embryos (at left) and two mutant embryos (at right), all from the
same litter. D, Quantification of thymic volumes at E18 (n=6 for each
sample). E,F, Transverse sections showing the thyroid (t) and
parathyroid (arrows; the parathyroids are also shown in Fig. S1B–C) in
a control (E) and mutant (F). G,H, Whole mount view of the palate to
show clefting (arrows) in the mutant (H).
doi:10.1371/journal.pone.0032429.g001
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types seen in late gestation embryos. There was a disruption in the
continuity of the atrial myocardium in all of five Tie2Cre/Nrp1
mutants examined for this phenotype (Fig. S1F–G), and in one of
seven examined mutants, there were mild defects in the structure
of the vertebral bodies (Fig. S1H). Comparable atrial and more
severe vertebral phenotypes were observed in Tie2Cre/plexinD1
mutants [34], but have not been reported in Vegfa mutants and are
not associated with DiGeorge syndrome. These defects therefore
are likely to represent defective semaphorin, not VEGF, signaling
through NRP1/plexinD1 complexes in endothelial cells.
Global heterozygosity of Nrp1, and endothelial-specific condi-
tional Nrp1 heterozygosity driven by Tie2Cre, are both viable and
apparently normal (i.e., no malformations were reported for these
genotypes) [31,33]. In our analysis of 14 Tie2Cre conditional
heterozygous Nrp1 mutants at E18.5, we did not see any
malformations in the cardiac outflow tract, the great vessels,
pharyngeal organs, or craniofacial structures.
Altered endothelial cell organization and outflow tract
cushions in Tie2Cre/Nrp1 mutants
We next explored the morphogenesis of the cardiac outflow
tract, the pharyngeal arch arteries and pharyngeal organs, and the
palate to determine if the comparable DGS-like phenotypes seen
in Tie2Cre/Nrp1 and Tbx1 mutants at late embryonic stages share a
common underlying developmental and mechanistic basis.
Tbx1 normally functions in pharyngeal and splanchnic meso-
derm [8,35] to maintain the second heart field (SHF), a progenitor
population that is added progressively to the distal end of the
cardiac outflow tract during the E8–11 period of development
[36]. This process allows the OFT to lengthen and thereby achieve
a characteristic looped shape by E10.5, and is necessary for
septation to occur during the E10.5–11.5 period. In Tbx1 null
embryos at E10.5, as also previously reported [37], the OFT was
shortened and poorly looped (Fig. 2A–B). In contrast, the
morphology (length and degree of looping) of the OFT was
normal in all E10.5 Tie2Cre/Nrp1 mutants (Fig. 2C–D). ISL1, a
marker of the SHF, was normally expressed in Tie2Cre/Nrp1
mutants (Fig. 3A–B), whereas the domain of ISL1 expression is
reduced in Tbx1 mutants [38]. MF20, a marker of differentiated
myocardium, was properly expressed in Tie2Cre/Nrp1 mutants up
to the distal end of the OFT (Fig. 3C–D), whereas MF20
expression extends into the splanchnic mesoderm in Tbx1 mutants
because of premature myocardial differentiation [38–39]. These
observations imply that the early aspects of SHF differentiation
that are controlled by Tbx1 are normal in Tie2Cre/Nrp1 mutants.
Neural crest cells are required for OFT septation [40]. NC cells
that reach the distal end of the OFT begin to differentiate and
express smooth muscle actin (SMA). In Tbx1 mutants, NC cell
migration to the OFT is disrupted [2,41]. In contrast, we observed
a normal number and distribution of SMA-positive cells (of
presumptive NC origin) at and around the distal OFT of Tie2Cre/
Nrp1 mutants (Fig. 3E–F). We also crossed the conditional lacZ
reporter allele R26R into the Tie2Cre conditional mutant
background and visualized endocardium and endocardium-
derived cells in the OFT by Xgal staining. Unstained mesenchy-
mal cells in the OFT are of presumptive NC origin, as the only
known sources of OFT mesenchyme are NC and transformed
endocardium [32,42]. The amount and distribution of unstained
and stained mesenchyme in the OFT was normal in control and
Tie2Cre/Nrp1 mutants (Fig. 3G–J). Thus, there does not appear to
be any apparent defect in NC migration into the OFT that might
account for septation failure. Proliferation of mesenchymal neural
crest cells and of endothelial cells in the distal OFT was normal
(Fig. 3K), and there was also no obvious alteration in endocardium
transformation to mesenchyme in the proximal OFT or in the
atrioventricular canal (Fig. 3I–J).
Outflow septation involves the growth and fusion of two opposing
mesenchymal cushions across the lumen of the OFT [43]. These
cushionsformbythemigrationofNCcellsbetweentheendocardium
and myocardium, and close to the right ventricle, the outflow tract
cushions also contain endocardium-derived mesenchyme [42]. In
Tie2Cre/Nrp1 mutants, OFT cushion number and morphology were
disorganized. This was seen most clearly in sections orthogonal to the
outflow tract (Fig. 3G–J): in normal embryos, the endocardium and
myocardium were juxtaposed at two opposite locations (between the
two mesenchymal cushions), whereas in mutants, there were multiple
sites of association between the endocardium and myocardium (i.e.,
multiple cushions), and with abnormal attachment of the endocar-
dium to the myocardium.
Valve leaflets form from the distal (truncal) segment of the
outflow tract cushions. In normal embryos following septation,
both vessels have three valve leaflets. In Tie2Cre/Nrp1 mutants, we
observed a variable number of leaflets (2–4 or more), with these
having a range of sizes and morphologies (Fig. S2). Abnormal
OFT cushion number and organization therefore might be the
initial anatomical defect that leads to improper septation and then
also to valve leaflet disorganization.
Figure 2. Outflow tract morphology in Tbx1 and Tie2Cre/Nrp1
mutants. All hearts shown are from E10.5 embryos. A,B, control and
littermate Tbx1 null hearts, showing the straight and shortened OFT and
the smaller right ventricle in the Tbx1 mutant. C,D, control (Tie2Cre/
R26R) and littermate Tie2Cre/R26R/Nrp1 mutant, Xgal stained in whole
mount, and showing the normal looping of the OFT in Tie2Cre/Nrp1
mutants. Panels A9,B9,C9,D9 are traced outlines of the same hearts
shown in the corresponding panels to more easily compare the
absence of outflow tract lengthening and looping in the Tbx1 mutant to
the normal looping in the Tie2Cre/Nrp1 mutant.
doi:10.1371/journal.pone.0032429.g002
Neuropilin and DiGeorge Syndrome Malformations
PLoS ONE | www.plosone.org 3 March 2012 | Volume 7 | Issue 3 | e32429Defective arch artery formation in Tie2Cre/Nrp1 mutants
The pharyngeal arch arteries form sequentially as the
connections between the outflow tract and systemic circulation.
At E10.5, the 1
st and 2




th arch arteries are organized in a bilaterally symmetric
pattern, connecting to the right and left dorsal aortae. From E11,
these arch arteries and segments of the dorsal aortae are
reorganized in a highly asymmetric manner to form the mature
great vessels [44]. We performed ink injection into the hearts of
E10.5 embryos in order to visualize the pattern of arch arteries in
control vs. Tie2Cre/Nrp1 mutants (Fig. 4). The most common
defect, seen in 8 of 10 mutant embryos, was a bilateral absence or
hypoplasia of both 4
th arch arteries (Fig. 4B). In two of these, both
6
th arch arteries were also missing, and in one embryo, only the
right 6
th arch artery was also missing. One mutant had a missing
right 6
th arch artery with normal 4
th arch arteries (Fig. 4C), and
one mutant had what appeared to be a normal arch artery
organization. These arch artery defects at E10.5 are consistent
with the great vessel malformations seen in E18.5 mutant embryos
as described above. In Tie2Cre/Nrp1 mutants, smooth muscle
differentiation around arch arteries that were properly formed
appeared normal (Fig. 3E–F).
Heterozygosity of Tbx1 in mice results in a moderate frequency
of 4
th arch artery defects [2–4]. In contrast, no arch artery defects
were observed in 13 Tie2Cre endothelial-specific conditional Nrp1
heterozygotes at E10.5 (littermates of those described above), and
as noted earlier, no defects were observed in the great vessels or
elsewhere in E18.5 conditional Nrp1 heterozygous embryos. Arch
artery defects were also not observed among 24 littermate embryos
at E10.5 that lacked the Tie2Cre gene.
Impaired thymic vascular development in Tie2Cre/Nrp1
mutants
The thymus and parathyroids are derived from the 3
rd
pharyngeal pouch. As also previously observed [2,35,45], Tbx1
mutants lacked proper segmentation of the pharyngeal arches and
pouches (Fig. 5A–B), which compromises the formation of the
thymus and parathyroid organs. In contrast, in every Tie2Cre/Nrp1
mutant embryo, we observed normal pharyngeal pouch organi-
zation, even as pharyngeal arch artery development was obviously
compromised (Fig. 5C–D). Thus, the pharyngeal organ defects of
E18.5 Tie2Cre/Nrp1 mutants do not share a common develop-
mental etiology with the similar malformations seen in Tbx1
Figure 3. Markers of outflow tract morphogenesis. Upper row in all pairs of panels is a control, lower row is a littermate Tie2Cre/Nrp1 mutant.
A,B, Immunohistochemical detection of ISL1 at E10.5 (sagittal section); the brackets indicate the ISL1
+ second heart field. C,D, Immunohistochemical
detection of MF20 at E10.5 (sagittal section); the arrows point to the distal limit of myocardium in the outflow tract. E,F, Immunohistochemical
detection of smooth muscle actin at E11.25 in the outflow tract (transverse section); the asterisks show the location of immunoreactive mesenchyme
of presumptive neural crest derivation at the distal end of the outflow tract. In the control, OFT septation is underway although not yet completed,
whereas in the mutant, this process fails, resulting in a common arterial trunk (CAT). Positive staining is also apparent in scattered mesenchyme cells
lower in the truncal cushions of the outflow tract, and in differentiating smooth muscle surrounding the 6
th arch arteries (6). At this stage, SMA also
labels myocardium. G–J, Orthogonal sections of Xgal-stained Tie2Cre/R26R distal outflow tracts from two different control (G,I) and two different
Tie2Cre/R26R/Nrp1 (H,J) E10.5 embryos; the endocardium is Xgal-positive whereas the mesenchyme is unlabeled and therefore of presumptive neural
crest derivation. Arrows point to the juxtapositions between the endocardium and the myocardium that separate OFT cushions; there are two such
points in controls, and several in mutants indicating abnormal cushion number and organization. Note also the normal extent of Xgal
+ mesenchyme
derived by endocardial transformation in the atrioventricular canal (AVC; I,J). K, OFT cell proliferation at E10.5; embryos were BrdU labeled and
sections through the distal OFT were immunstained to detect proliferating cells. Mesenchymal cells are of presumptive neural crest derivation,
endothelial cells (EC) were identified based on morphology.
doi:10.1371/journal.pone.0032429.g003
Figure 4. Pharyngeal arch artery organization visualized by ink
injection at E10.5. A, Normal arterial pattern in a control embryo; the
numbers 3, 4, and 6 indicate the respective arch arteries. B,C, Examples
of arch artery abnormalities seen in mutant embryos: an extremely
hypoplastic 4
th arch artery (B), and a missing 6
th arch artery (C), both
indicated by asterisks.
doi:10.1371/journal.pone.0032429.g004
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artery and great vessel defects in Tie2Cre/Nrp1 mutants described
above do not occur as the indirect result of pharyngeal
disorganization.
Thymic morphology and size at E12.5 was normal in Tie2Cre/
Nrp1 mutants, but hypoplasia became apparent at E13.5 and
persisted proportionally as development proceeded. TUNEL
staining showed no difference in apoptosis at any stage (Fig. S3).
We used PECAM1 immunostaining to visualize vascular organi-
zation in the developing thymus. In normal development, blood
vessels initiate assembly around the periphery of the thymus at
E12.5 [46], and this occurred properly in mutants (Fig. 6A–B). At
E13.5, in control embryos, peripheral vessels were still present and
in addition several intrathymic vessels had also formed, whereas in
Tie2Cre/Nrp1 mutants, peripheral vessels were present but with few
if any internal vessels (Fig. 6C–D). In control embryos at E14.5,
extensive intrathymic vessels were present and now with few
peripheral vessels, whereas in mutants, the majority of vessels were
still at the thymic perimeter with fewer and less complex
intrathymic structures (Fig. 6E–F). Thus, thymic vascular
formation is deficient or delayed in Tie2Cre/Nrp1 mutants.
Reduced palatal mesenchyme cell proliferation in
Tie2Cre/Nrp1 mutants
The palate forms from opposed shelves in the oral cavity that
first elevate, grow towards each other, and then fuse. In normal
development, the palatal shelves contact each other at E14.5 and
by subsequent breakdown of the medial epithelium become fused
at E15.5 [47]. Cleft palate was present in approximately half of
E18.5 Tie2Cre/Nrp1 mutants (described above). We examined
younger embryos to determine the basis of this phenotype. At
E14.5, we observed a spectrum of palatal shelf hypoplasia, ranging
from failure to elevate to various degrees of incomplete growth
(Fig. 7A–D). We also observed fusing palatal shelves in
approximately half of examined mutant embryos at E14.5
(Fig. 7E), which is consistent with the range of phenotypes scored
at E18.5.
In Tbx1 nulls, cleft palate is a highly penetrant phenotype, and
analysis at E14.5 showed a diminishment of palate shelf size [48],
similar to what we observed in approximately half of the Tie2Cre/
Nrp1 mutants. In Tbx1 nulls, there is an increase in palatal
mesenchyme cell proliferation that is more than counterbalanced
by an increased level of apoptosis, resulting in insufficient net
growth and thereby in clefting [48]. In contrast, a similar analysis
of Tie2Cre/Nrp1 mutants revealed a significant decrease in cell
proliferation (Fig. 7F–H) and no change in apoptosis (Fig. 7I–J).
Thus, the cellular basis of cleft palate in the two models is distinct.
The mesenchyme of the palatal shelves is derived almost
completely from neural crest, so a decrease in palatal mesenchyme
cell proliferation must be an indirect consequence of Nrp1
disruption in endothelium. We used PECAM1 immunostaining
to visualize the developing vasculature in the palatal shelves. At
E12.5, we consistently observed fewer blood vessels in mutants
compared to controls (Fig. 7K–L). This may be the initial defect
that leads to decreased mesenchymal cell proliferation and thereby
to cleft palate. At E13.5 and E14.5, vascular distribution was more
variable in mutants and often resembled controls; this may explain
why palate fusion was achieved in approximately half of mutant
embryos by E14.5.
Lack of genetic interaction between Nrp1 and Tbx1
In mice, the primary phenotype in Tbx1 heterozygotes is a
variable penetrance of 4
th arch artery hypoplasia (resulting in type B
interrupted aortic arch in later embryos), although the penetrance
of this phenotype is strain-dependent. All other DGS defects
occur when Tbx1 is homozygous, or when Tbx1 heterozygosity is
combined with mutation of another interacting gene. We addressed
whether heterozygous Nrp1 deficiency in the Tie2Cre domain
synergized withglobal heterozygous Tbx1deficiency. In the outbred
Figure 5. Pharyngeal morphology in Tbx1 and Tie2Cre/Nrp1
mutants. All panels are frontal sections of E10.5 embryos. A,B, control
and littermate Tbx1 null embryos; the Tbx1 mutant has no segmenta-
tion of the foregut (FG) pharyngeal endoderm. C,D, control and
littermate Tie2Cre/Nrp1 mutant, showing normal pharyngeal organiza-
tion in mutant embryos even when arch arteries are missing (in the
mutant, both 4
th arch arteries were extremely hypoplastic, indicated by
the asterisks). 3p, 4p, 3
rd and 4
th pharyngeal pouches; numbers indicate
pharyngeal arch arteries. A histology artifact is responsible for the
broken piece of the left 3
rd arch in the mutant shown.
doi:10.1371/journal.pone.0032429.g005
Figure 6. Deficient thymic growth and vascular organization in
Tie2Cre/Nrp1 mutants. Upper row in all pairs of panels is a control,
lower row is a littermate Tie2Cre/Nrp1 mutant. PECAM1 immunostained
transverse sections around the developing thymus (th) are shown; all six
images are at the same magnification. A,B, E12.5 embryos; C,D, E13.5
embryos; E,F, E14.5 embryos. Arrows in A and B point to nascent vessels
at the periphery of the E12.5 thymus, which are similar in control vs.
mutant embryos at this stage.
doi:10.1371/journal.pone.0032429.g006
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among 9 Tbx1 heterozygous embryos analyzed of interrupted aortic
arch nor of any other malformation. All of 7 Tie2Cre,Nrp1
fl/+,Tbx1
2/+
embryos, analyzed at E18, were also normal in all regards (Fig. S4),
implying no detectable enhancement of phenotypic penetrance.
The power of this analysis is limited by the absence of observed
phenotypes, and detection of a possible epistatic interaction might
require backcrossing onto a more susceptible genetic background.
However, the apparent lack of genetic interaction is fully consistent
with the observations described above showing a different cellular
and developmental basis for each DGS phenotype in Tie2Cre/Nrp1
and Tbx1 mutants. Collectively, our results imply that Tbx1 and
Nrp1 are parts of distinct pathways that lead to DGS malformations.
Discussion
In this study, we report that endothelium-specific disruption of
Nrp1 causes DiGeorge syndrome-type malformations in mice. An
unseptated outflow tract (common arterial trunk) was noted in an
earlier description of Tie2Cre/Nrp1 mutants [33], and global Nrp1
disruption was previously shown to result in early pharyngeal arch
artery defects [31] that would be manifest as great vessel
malformations if such embryos were able to survive to late
gestation. However, the constellation of cardiovascular outflow
tract, great vessel, pharyngeal organ, and craniofacial defects that
collectively typify DiGeorge syndrome had not been previously
recognized in Tie2Cre/Nrp1 mutants, and could not have been seen
(because of early lethality) in global Nrp1 mutants.
Because NRP1 functions as a coreceptor with VEGFR2 for
VEGF signals, and with plexins for Sema3 signals, Nrp1 mutant
phenotypes might reflect either or both signaling pathways. Cleft
palate or pharyngeal organ malformations are not known to result
from plexin or semaphorin gene mutations, but do occur in Vegfa
mutants, implying that these phenotypes in Tie2Cre/Nrp1 mutants
represent Vegfa signaling pathways. Cardiac outflow tract defects
are observed in Sema3c and in plexinD1 mutants as well as in Vegfa
mutants; however, a previous detailed genetic analysis showed that
NRP1 is required for VEGF but not for Sema3 signaling in this
tissue [33,49]. We conclude therefore that NRP1 is required as a
receptor for VEGF signals that are important in cardiac outflow
tract, arch artery, pharyngeal organ, and craniofacial development
(i.e., the organs impacted in DiGeorge syndrome). In contrast, the
atrial myocardium and vertebral defects seen in Tie2Cre/Nrp1
mutants are not known to occur in Vegfa mutants but are manifest
in Tie2Cre/plexinD1 mutants, implying that NRP1 serves as a
plexinD1 coreceptor for Sema3 signals that support the integrity of
the atrial myocardium and that mediate vertebral skeletal
organization.
One of the best known roles of VEGF is to support blood vessel
vasculogenesis and angiogenesis, and previous descriptions of Vegfa
[23,26–27] and Nrp1 [31,33] mutants reported a deficiency of
blood vessel density, specifically of medium and small caliber
vessels, in tissues throughout the embryo. We observed the same
type of deficiency in the palate and thymus of Tie2Cre/Nrp1
mutants, which may underlie the diminished growth of these
organs during mid- to late gestation. The great vessel defects seen
in this mutant background result from a failure of some of the
initial arch arteries to form. Vegfa is expressed in pharyngeal
endoderm [23–24], and is therefore in close proximity to influence
the behavior of NRP1-expressing endothelial cells in the
pharyngeal arches. We do not yet know if the primary defect is
in the initial organization of endothelial cells into nascent vessels,
or in their subsequent interaction with neural crest cells that is
required for vessel stabilization [50].
The outflow tract phenotype of Tie2Cre/Nrp1 mutants appears to
be qualitatively distinct from the vascular defects seen elsewhere in
these embryos. Vegfa is expressed in outflow tract myocardium [23–
25], and our results suggest that it signals through NRP1 in the
endocardium to facilitate cushion organization, which is required
for subsequent septation and valve formation. Distortion of OFT
cushionorganization is likely to be the underlying cause of the single
persisting outflow vessel in Tie2Cre/Nrp1 mutants, as the ultimate
fusion of these malformed and mispositioned cushions would result
in the obstruction of one of the two outflow channels [51].
Figure 7. Reduced palatal mesenchyme cell proliferation in Tie2Cre/Nrp1 mutants. A–E, frontal sections at E14.5 of control (A) and of
several mutant embryos (B–E) showing a range of palatal phenotypes: failure of the palatal shelves (ps) to elevate (B), gross and mild failure to
properly extend (C and D, respectively), and normal fusion (E; approx. half of mutants had normally fused palates). F,G, Proliferation detected by
phospho-histone H3 immunohistochemistry in frontal sections of control (F) and Tie2Cre/Nrp1 (G) embryos at E13.5 (nuclei are counterstained with
hematoxylin); the dotted line shows the approximate upper end of the palatal shelves for purposes of quantification of proliferating cells. H,
Quantification of mesenchymal proliferation in E13.5 palatal shelves. I,J, Absence of palatal shelf apoptosis at E13.5 in frontal sections, visualized by
immunostaining for activated caspase 3. K,L, Immunohistochemical detection of PECAM1 in control (K) and mutant (L) embryos (frontal sections) in
the palatal shelves at E12.5. The bracket indicates the region of growth and extension; there are fewer and less well elaborated vessels in this region
in the mutant. The avascular region behind the brackets in both panels is condensed mesenchyme that will form the maxillae. tb, tooth bud.
doi:10.1371/journal.pone.0032429.g007
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with mutation of the Tbx1 gene, and in mice, the terminal DGS
phenotypes of Tie2Cre/Nrp1 and Tbx1 mutants are similar.
Nonetheless, our analysis revealed fundamental differences in the
developmental process that lead to these phenotypes in the two
mutant backgrounds. Thus, in Tbx1 mutants, a second heart field
deficiency leads to a shortened and misaligned outflow tract
[8,35,37] (Fig. S2A–B), defective neural crest cell migration and/
or smooth muscle differentiation appear to be responsible for arch
artery defects [2,7,41,52], disorganization and lack of segmenta-
tion of the pharyngeal endoderm results in pharyngeal organ
defects [2,35,45] (Fig. 5A–B), and elevated mesenchymal apoptosis
leads to cleft palate [48]. None of these events occur in Tie2Cre/
Nrp1 mutants. Instead, we have described alternate developmental
processes that explain the various phenotypes. If Nrp1 and Tbx1
converge in a functionally relevant manner, we would predict not
only similar terminal mutant phenotypes but also similar
intermediate developmental manifestations, which we did not
see. Our results lead to the conclusion that a broad range of DGS
phenotypes can occur as the result of disruption of a single gene
(Nrp1) and through mechanisms that are distinct from those
associated with Tbx1.
We believe that our conclusion of a Tbx1-independent pathway
leading to the spectrum of defects that typify DGS is novel. Many
mouse gene mutations result in a similar range of DGS-type
malformations, but these genes have either been shown to interact
genetically or mechanistically with Tbx1 and therefore impair the
same developmental processes as does Tbx1, or simply have not
been examined in detail. Many other gene mutations cause
individual phenotypes but not the larger constellation of DGS
malformations, and these clearly need not intersect with Tbx1.I ti s
also noteworthy that no previous genetic manipulation that results
in the broad spectrum of DGS-type defects has been shown to
involve the endothelium, and in the case of Tbx1, an endothelial
role has been disproven [8–10]. One possible example similar to
Nrp1 involves the endothelin signaling system, where mutation of
the ligand gene Edn1 [53–54], of the receptor gene Ednra [55], or
of the converting enzyme gene Ece1 [56–57] all lead to DGS-type
malformations. Analysis of Tbx1-Ece1 trans heterozygotes failed to
reveal genetic interaction [58], as we also observed between Tbx1
and Nrp1. However, if endothelin is part of the VEGFA-NRP1
axis rather than part of the TBX1 pathway, the relationship must
be indirect: Ednra function in neural crest cells is required for the
normal morphogenesis of the cardiac outflow tract, arch arteries,
pharyngeal organs, and craniofacial structures [59], although
endothelial-specific mutation of Edn1 caused no developmental
malformations [60].
Vegfa has been proposed as a genetic modifier of the
chromosome 22q11 deletion syndrome [23], based on several
criteria: the occurrence of similar phenotypes in mouse Vegfa
mutants as in Tbx1 mutants, the observation of genetic synergy
between vegfa and tbx1 in zebrafish embryos specifically for arch
artery defects, a Vegfa haplotype in humans that was associated
with increased incidence of cardiovascular phenotypes in chro-
mosome 22q11 patients, and finally by the decreased expression of
Tbx1 in the pharyngeal region of E10.5 Vegfa mutant mouse
embryos. Tie2Cre/Nrp1 and Vegfa mouse mutants share most DGS-
related phenotypes, yet our results imply that Tbx1 is not involved
in the etiology of any of the Tie2Cre/Nrp1 defects. Thus, it may also
not be necessary to invoke Tbx1 to explain most of the Vegfa
deficient phenotypes. A prior study also questioned whether non-
Tbx1-dependent mechanisms explain the effects of VEGF on
pharyngeal arch artery development [9]. At the same time, in
some tissues that are outside of the Tie2Cre recombination domain,
VEGF may also regulate or intersect with Tbx1. This may for
example explain the reported decrease in Tbx1 expression in the
pharyngeal arch region of Vegfa mutants, and the higher incidence
and severity of mandible hypoplasia in Vegfa mutants compared to
Tie2Cre/Nrp1 mutants.
With the exception of the outflow tract phenotype, the other
VEGF-dependent defects observed in Tie2Cre/Nrp1 mutants
appear to reflect deficient vascular formation (great vessel defects)
or angiogenesis (for the thymus and palate). Deficient vascular
organization has previously been associated with teratogen-
induced and spontaneous cleft palate [61–62], and a ‘‘vascular
hypothesis’’ has been proposed to more broadly explain DiGeorge
syndrome phenotypes as the consequences of vascular insufficiency
[63]. Clearly in the case of chromosome 22q11 deletion syndrome
and for Tbx1 mutation, a disruption of earlier processes is a more
suitable explanation for these defects. However, our results suggest
that VEGF- and NRP1-dependent vascular defects can result in
many DGS phenotypes in a manner that is independent of and
later in developmental time than when the Tbx1 gene functions, at
least as Tbx1 function is currently understood.
There is an alternative interpretation of our observations and of
those from past studies that we cannot formally exclude. TBX1
clearly controls many early developmental processes in an NRP1-
independent manner that when compromised result in DGS.
However, Tbx1 might in addition also control VEGF signaling to
endothelial NRP1 in a way that accounts for the later alternative
defects that we observed in Tie2Cre/Nrp1 mutant embryos. The
lack of genetic interaction between Tbx1 and Nrp1 argues against
this model, although the negative result does not disprove its
possibility. If this model is true, Tbx1 controls two independent sets
of processes (earlier NRP1-independent and later VEGF/NRP1-
dependent) that both lead to the same spectrum of DGS
phenotypes. This would be a novel aspect of Tbx1 function that
has been obscured by all of the early (NRP1-independent) defects
that alone are sufficient to explain DGS phenotypes in Tbx1-null
embryos.
In Tie2Cre/Nrp1 mutants, deficient vascular organization is not
confined to only the cardiac outflow tract, pharyngeal arch
arteries, pharyngeal organs, and palate; similar vascular deficien-
cies occur throughout the embryo [33], including many organs
that are not grossly impacted by Nrp1 mutation and that are not
part of the DGS spectrum. This is also true for Vegfa mutation
[23,26–27]. VEGF signaling through endothelial NRP1 is
therefore responsible for local vasculogenesis and angiogenesis,
although most tissues are not apparently affected when this process
is compromised. The unexpected observation is that the tissues
that are most commonly impacted in DiGeorge syndrome appear
to be particularly dependent on VEGF-NRP1 signaling. It has
long been appreciated that neural crest cells contribute to the
tissues that are compromised in DGS. Thus, NC cells are required
for OFT septation [40], support the formation of the pharyngeal
arch arteries [50], form the pericytes and smooth muscle of the
thymic vasculature [64–66], and contribute virtually all of the
mesenchyme that allows growth of the palatal shelves [47].
Moreover, ablation of the NC can phenocopy DGS [67]. We
speculate that a VEGF-dependent interaction between endothelial
and neural crest cells may account for the restricted (DGS
spectrum) distribution of phenotypic consequences in Tie2Cre/
Nrp1 and Vegfa mutants. For arch artery formation and cardiac
outflow tract septation, this might involve a direct physical or
signaling interaction between VEGF-activated endothelial cells
and neural crest cells. Alternatively, neural crest cells are thought
to be particularly sensitive to hypoxia [68–69], and organs such as
the thymus or palate that depend on NC cells for their growth
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deficiency.
Most cases of DGS in humans are associated with Tbx1
deficiency; however, a number of DGS patients lack chromosome
22 deletions and do not appear to have mutations in the Tbx1 gene
[70]. A second DGS locus has been postulated to reside on human
chromosome 10 [71–72], in the vicinity of the Nrp1 gene. Nrp1
may therefore be a candidate gene to explain DGS phenotypes in





2/+ [3], and R26R [73]
mice were bred according to standard protocols. All animal work
was conducted according to relevant national and international
guidelines. Full details of this study were reviewed and approved
by the USC IACUC (protocol #10848).
Immunohistochemistry
Embryos were fixed in 4% PFA overnight at 4uC, then
dehydrated in an ethanol series and embedded in paraffin, and
sectioned at 10 m thickness. Following dewaxing and rehydration,
primary antibodies used were against MF20 (Developmental
Studies Hybridoma Bank; 1:20 dilution), ISL1 (Developmental
Studies Hybridoma Bank; 1:20), and SMA (Sigma, 1:1000). For
BrdU detection, pregnant females were injected with 100 mg/g
body weight BrdU 2 hr before sacrifice, followed by fixation,
paraffin embedding, and sectioning as above; primary antibody
was from the BrdU Staining kit (Invitrogen). For detection of
CD31 (BD Pharmingen MEC13.3; 1:400) and phospho-histone
H3 (Cell Signaling; 1:100), embryos were fixed as above then
transferred to 10% and then 30% sucrose, then embedded in
OCT on dry ice, and 10 m frozen sections were cut. Biotin-
conjugated secondary antibodies (Santa Cruz, 1:300) were used
according to the primary antibody species. Streptavidin-HRP was
applied to slides after secondary antibody incubation; signal was
detected with the DAB Plus kit (Invitrogen). In general, sections
were counterstained with hematoxylin prior to mounting.
In situ hybridization
Embryos were isolated in RNase free PBS on ice. The isolated
embryos were fixed in 4% PFA overnight at 4uC, then transferred
to 10% and then 30% sucrose, then embedded in OCT on dry ice.
10 m sections were cut. Digoxygenin-labeled PTH probe was made
by in vitro transcription from a template obtained from N.
Manley. Signals were detected with anti-digoxygenin alkaline
phosphatase-coupled antibody (Roche) and BM Purple substrate
kit (Roche).
Ink injection
Embryos were isolated and kept in PBS on ice. The body wall
was opened and the right ventricle exposed; India ink (Martin’s
Bombay Black, diluted in PBS as needed) was injected directly into
the right ventricle by mouth pipetting with a drawn out glass
micropipet. Embryos were then fixed in 4% PFA overnight.
X-gal staining
Embryos were isolated on ice and fixed with 0.2% glutaralde-
hyde at 4uC for 10 min, then whole mount stained in Xgal at
room temperature overnight. For sections, stained embryos were
processed to 10% and 30% sucrose, then embedded and frozen in
OCT. 10 m sections were rinsed in PBS and counterstained with
nuclear fast red.
TUNEL assay
Paraffin sections were cut at 10 m; the remaining procedures
were done according to the In Situ Death Detection kit protocol
(Roche). The positive controls were prepared from sections of the
same embryos by preincubation with DNaseI to induce DNA
strand breaks, according to the kit protocol.
Bone and cartilage staining
E18.5 embryos were isolated and fixed in 95% ethanol
overnight. Following a brief rinse in deionized water, cartilage
was stained with alcian blue (0.05% alcian blue 8GX/5% acetic
acid in distilled water) for 24 hours. Stained embryos were washed
in 70% ethanol for 6–8 hr, then transferred to 1% potassium
hydroxide overnight. Bone was stained with alizarin red (0.005%
(w/v) in 1% KOH) for 2–4 hr. The tissue was then cleared in 1%
KOH/20% glycerol for 2 or more days.
OFT valve staining
The OFT valve region of E18.5 embryos was dissected
manually, then fixed in 4% PFA overnight. The tissue was whole
mount stained with alcian blue (0.05% alcian blue 8GX/5% acetic
acid in distilled water) for 24 hr, then rinsed in water and
photographed using darkfield optics.
Supporting Information
Figure S1 Embryogenesis in Tie2Cre/Nrp1 mutants. A,
Comparison of E14.5 forelimbs from a control (top) and Tie2Cre/
Nrp1 mutant (below) littermates to show normal limb development.
B,C, In situ hybridization detection of parathyroid hormone to
visualize the parathyroids in a control (A) and mutant (B) embryo
at E18. D,E, Images of E14.5 heads of control (C) and mutant (D)
embryos; the arrowhead in E points to the one obvious example of
mandibular hypoplasia seen in this mutant background in this
study. The shiny appearance of the embryo in panel E is a lighting
artifact. F,G, Atrial myocardium at E14.5 in a control (F) and
mutant (G) embryo; in the mutant, the myocardium is detached
from the epicardium and is split into multiple pieces (two shown by
arrows). H, Skeletal preparation of one mutant embryo at E18.5
showing vertebral defects, specifically an incompletely formed
lumbar L2 vertebral body, and a partial fusion of the L7 and L8
vertebrae.
(TIF)
Figure S2 Visualization of valve leaflets at E18.5. A, A9,A
single control embryo shown from two slightly different angles to
visualize the aortic and pulmonary valves, each consisting of three
well-formed leaflets. B–E, Four different mutants all showing a
single outflow structure (i.e., a common arterial trunk) with a
variety of valve leaflet morphologies and organizations.
(TIF)
Figure S3 Absence of apoptosis in the developing
thymus. A,B, Sections of E14.5 embryos stained by TUNEL
labeling. Nuclei are counterstained in blue, and TUNEL-positive
cells are in green; there were virtually no positive cells in either
genotype. C, A positive control for staining is shown at the same
magnification.
(TIF)
Figure S4 No accentuated phenotypes in Tbx1-Nrp1
trans heterozygotes, all analyzed at newborn stage.
A,B, Palates were fully closed. C, Heart outflow septation and
great vessels were normal. D, Thymic size was normal.
(TIF)
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